<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antimicrobial Chemotherapy - Pharmacology Study Guide</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>ü¶†</span>
                        <span>Topic 02</span>
                    </div>
                    <h1 class="document-title">Antimicrobial Chemotherapy</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Antibiotics, Antivirals, Antifungals & Antiparasitics</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>60 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Introduction -->
                    <section class="content-section" id="introduction">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß™</span>
                                Principles of Antimicrobial Therapy
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Antimicrobial chemotherapy involves the use of drugs to selectively kill or inhibit the growth of microorganisms while causing minimal damage to the host.</p>
                            
                            <div class="key-points-section" style="margin: 2rem 0;">
                                <div class="key-points-wrapper">
                                    <div class="key-points-header">
                                        <span class="key-points-icon">üîë</span>
                                        <h3 class="key-points-title">Key Concepts</h3>
                                    </div>
                                    <ul class="key-points-list">
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div><strong>Bactericidal:</strong> Drugs that kill bacteria (e.g., Penicillins, Aminoglycosides). Essential in life-threatening infections or immunocompromised patients.</div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div><strong>Bacteriostatic:</strong> Drugs that inhibit bacterial growth/replication (e.g., Tetracyclines, Sulfonamides), relying on the host's immune system to clear the infection.</div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div><strong>Spectrum:</strong> Range of activity. <em>Narrow</em> (specific groups) vs <em>Broad</em> (covers Gram +ve and -ve).</div>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Cell Wall Inhibitors -->
                    <section class="content-section" id="beta-lactams">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß±</span>
                                Cell Wall Synthesis Inhibitors (Beta-Lactams)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Beta-lactam antibiotics inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing cross-linking of peptidoglycan. They are generally <strong>bactericidal</strong>.</p>

                            <h3>1. Penicillins</h3>
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Class</th>
                                                <th>Examples</th>
                                                <th>Notes</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Narrow Spectrum</strong></td>
                                                <td>Benzylpenicillin (Pen G), Phenoxymethylpenicillin (Pen V)</td>
                                                <td>Pen G is acid-labile (parenteral). Pen V is acid-stable (oral). Active against Gram +ve cocci.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Anti-Staphylococcal</strong></td>
                                                <td>Cloxacillin, Flucloxacillin, Methicillin</td>
                                                <td>Resistant to penicillinase (beta-lactamase). Used for Staph infections.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Broad Spectrum</strong></td>
                                                <td>Ampicillin, Amoxicillin</td>
                                                <td>Better Gram -ve coverage. Amoxicillin has better oral absorption.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Anti-Pseudomonal</strong></td>
                                                <td>Piperacillin, Ticarcillin</td>
                                                <td>Extended spectrum including <em>Pseudomonas aeruginosa</em>.</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <div class="callout callout--tip">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Beta-Lactamase Inhibitors</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Substances like <strong>Clavulanic Acid</strong> are combined with penicillins (e.g., Co-amoxiclav = Amoxicillin + Clavulanic Acid) to protect the antibiotic from destruction by bacterial beta-lactamase enzymes.</p>
                                </div>
                            </div>

                            <h3>2. Cephalosporins</h3>
                            <p>Classified by generations. As you move from 1st to 4th generation, Gram-negative activity increases, and Gram-positive activity generally decreases (though 4th gen retains Gram +ve activity).</p>
                            
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker">1</div>
                                    <div class="list-content"><strong>1st Gen (e.g., Cephalexin):</strong> Good for Gram +ve skin/soft tissue infections.</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker">2</div>
                                    <div class="list-content"><strong>2nd Gen (e.g., Cefuroxime):</strong> Better Gram -ve coverage (H. influenzae).</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker">3</div>
                                    <div class="list-content"><strong>3rd Gen (e.g., Ceftriaxone):</strong> Excellent Gram -ve coverage, crosses Blood-Brain Barrier (Meningitis).</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker">4</div>
                                    <div class="list-content"><strong>4th Gen (e.g., Cefepime):</strong> Broad spectrum, resistant to beta-lactamases.</div>
                                </li>
                            </ul>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Limitations ("LAME")</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Cephalosporins are generally <strong>NOT</strong> active against:</p>
                                    <ul>
                                        <li><strong>L</strong>isteria</li>
                                        <li><strong>A</strong>typicals (Mycoplasma, Chlamydia)</li>
                                        <li><strong>M</strong>RSA</li>
                                        <li><strong>E</strong>nterococci</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Protein Synthesis Inhibitors -->
                    <section class="content-section" id="protein-synthesis">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Protein Synthesis Inhibitors
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Tetracyclines (e.g., Doxycycline)</h3>
                            <p><strong>MOA:</strong> Bind 30S ribosomal subunit. Bacteriostatic.<br>
                            <strong>Adverse Effects:</strong> Tooth discoloration (avoid in children <8yrs & pregnancy), phototoxicity, GI distress.<br>
                            <strong>Note:</strong> Absorption impaired by milk/antacids (calcium/magnesium chelation).</p>

                            <h3>Aminoglycosides (e.g., Gentamicin, Streptomycin)</h3>
                            <p><strong>MOA:</strong> Bind 30S ribosomal subunit. Bactericidal. Poor oral absorption (given IV/IM).<br>
                            <strong>Adverse Effects:</strong> <strong>Ototoxicity</strong> (irreversible deafness/vertigo) and <strong>Nephrotoxicity</strong> (reversible).</p>

                            <h3>Macrolides (e.g., Erythromycin, Azithromycin)</h3>
                            <p><strong>MOA:</strong> Bind 50S ribosomal subunit. Bacteriostatic.<br>
                            <strong>Uses:</strong> Penicillin-allergic patients, atypical pneumonia, H. pylori.<br>
                            <strong>Adverse Effects:</strong> GI upset (nausea/vomiting), cholestatic jaundice, enzyme inhibition (Erythromycin).</p>

                            <h3>Chloramphenicol</h3>
                            <p><strong>MOA:</strong> Binds 50S subunit. Broad spectrum but toxic.<br>
                            <strong>Adverse Effects:</strong> Bone marrow suppression (Aplastic anemia), <strong>Gray Baby Syndrome</strong> in neonates (due to inability to conjugate the drug).</p>
                        </div>
                    </section>

                    <!-- Section 4: Nucleic Acid & Metabolic Inhibitors -->
                    <section class="content-section" id="nucleic-acid">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Nucleic Acid & Metabolic Inhibitors
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Fluoroquinolones (e.g., Ciprofloxacin)</h3>
                            <p><strong>MOA:</strong> Inhibit DNA Gyrase (Topoisomerase II) involved in DNA replication. Bactericidal.<br>
                            <strong>Adverse Effects:</strong> Tendonitis/tendon rupture, cartilage damage (avoid in children), CNS effects.</p>

                            <h3>Sulphonamides & Trimethoprim (Antifolates)</h3>
                            <p><strong>MOA:</strong> Inhibit steps in folic acid synthesis (essential for DNA).<br>
                            <strong>Cotrimoxazole (Septrin):</strong> Combination of Sulfamethoxazole + Trimethoprim (Synergistic).<br>
                            <strong>Adverse Effects:</strong> Crystalluria (drink water), Stevens-Johnson Syndrome (hypersensitivity), Kernicterus in newborns.</p>

                            <h3>Metronidazole</h3>
                            <p><strong>MOA:</strong> Active against <strong>anaerobes</strong> and <strong>protozoa</strong>. Disrupts DNA structure.<br>
                            <strong>Uses:</strong> Amoebiasis, Giardiasis, Trichomoniasis, anaerobic bacterial infections.<br>
                            <strong>Warning:</strong> Disulfiram-like reaction with alcohol (severe vomiting).</p>
                        </div>
                    </section>

                    <!-- Section 5: Antimycobacterial Agents -->
                    <section class="content-section" id="tb-leprosy">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü´Å</span>
                                Antimycobacterial Agents (TB & Leprosy)
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Anti-Tuberculosis Drugs</h3>
                            <p>Standard treatment involves combination therapy to prevent resistance. Two phases: Intensive (2 months) & Continuation (4 months).</p>

                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Drug</th>
                                                <th>Key Adverse Effects</th>
                                                <th>Notes</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Isoniazid (H)</strong></td>
                                                <td>Peripheral neuropathy, Hepatotoxicity</td>
                                                <td>Give Vitamin B6 (Pyridoxine) to prevent neuropathy.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Rifampicin (R)</strong></td>
                                                <td>Hepatotoxicity, Orange/Red body fluids</td>
                                                <td>Potent enzyme inducer (drug interactions).</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Pyrazinamide (Z)</strong></td>
                                                <td>Hepatotoxicity, Hyperuricemia (Gout)</td>
                                                <td>Active in acidic pH (macrophages).</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Ethambutol (E)</strong></td>
                                                <td>Optic Neuritis (Red/Green color blindness)</td>
                                                <td>Dose adjustment in renal failure.</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Streptomycin (S)</strong></td>
                                                <td>Ototoxicity, Nephrotoxicity</td>
                                                <td>Injectable aminoglycoside.</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h3>Anti-Leprosy Drugs</h3>
                            <p><strong>Dapsone:</strong> Sulfonamide-like. SE: Hemolysis (G6PD deficiency), Methemoglobinemia.<br>
                            <strong>Clofazimine:</strong> Red-brown skin discoloration.<br>
                            <strong>Rifampicin:</strong> Also used in leprosy.</p>
                        </div>
                    </section>

                    <!-- Section 6: Antifungal & Antiviral -->
                    <section class="content-section" id="antifungal-antiviral">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üçÑ</span>
                                Antifungal & Antiviral Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Antifungals</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Polyenes (Amphotericin B, Nystatin):</strong> Bind ergosterol, creating pores. Amphotericin B is for severe systemic fungal infections (very nephrotoxic).</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Azoles (Fluconazole, Ketoconazole):</strong> Inhibit ergosterol synthesis. Drug interactions common (inhibit CYP enzymes).</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Griseofulvin:</strong> Oral drug for dermatophyte (skin/nail) infections. Take with fatty meal.</div>
                                </li>
                            </ul>

                            <h3>Antivirals</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Anti-Herpes (Acyclovir):</strong> Inhibits viral DNA polymerase. Used for HSV, VZV.</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Anti-Retrovirals (ARVs for HIV):</strong>
                                        <br>‚Ä¢ <strong>NRTIs:</strong> Zidovudine (Bone marrow suppression), Lamivudine.
                                        <br>‚Ä¢ <strong>NNRTIs:</strong> Efavirenz, Nevirapine (Hepatotoxicity, Rash).
                                        <br>‚Ä¢ <strong>Protease Inhibitors:</strong> Ritonavir, Lopinavir (Metabolic syndrome).
                                    </div>
                                </li>
                            </ul>
                        </div>
                    </section>
                    
                    <!-- Section 7: Antiparasitic Agents -->
                    <section class="content-section" id="antiparasitic">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶ü</span>
                                Antiparasitic Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Antimalarials</h3>
                            <ul>
                                <li><strong>Artemether-Lumefantrine (AL):</strong> First-line for uncomplicated malaria.</li>
                                <li><strong>Quinine:</strong> For severe/complicated malaria. SE: Cinchonism (tinnitus, headache), Hypoglycemia.</li>
                            </ul>

                            <h3>Anthelminthics</h3>
                            <ul>
                                <li><strong>Benzimidazoles (Albendazole, Mebendazole):</strong> Inhibit microtubule synthesis. Used for nematodes (worms).</li>
                                <li><strong>Praziquantel:</strong> For Schistosomiasis and tapeworms.</li>
                            </ul>
                        </div>
                    </section>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-01-general-pharmacology.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">General Principles</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>02</span>
                                <span class="progress-separator">/</span>
                                <span>05</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 40%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>
                        
                        <a href="topic-03-nervous-system.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Nervous System</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="js/theme.js"></script>
    <script>
        // Reading progress indicator
        const progressBar = document.getElementById('reading-progress');
        
        function updateReadingProgress() {
            const scrollTop = window.pageYOffset || document.documentElement.scrollTop;
            const scrollHeight = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrollPercent = (scrollTop / scrollHeight) * 100;
            
            progressBar.style.width = Math.min(scrollPercent, 100) + '%';
        }
        
        window.addEventListener('scroll', updateReadingProgress);
        
        // Active navigation highlighting
        function updateActiveNavigation() {
            const sections = document.querySelectorAll('.content-section');
            const navLinks = document.querySelectorAll('.floating-toc-list a');
            
            let currentSection = '';
            
            sections.forEach(section => {
                const sectionTop = section.offsetTop - 150;
                const sectionHeight = section.offsetHeight;
                
                if (window.pageYOffset >= sectionTop && window.pageYOffset < sectionTop + sectionHeight) {
                    currentSection = section.getAttribute('id');
                }
            });
            
            navLinks.forEach(link => {
                link.classList.remove('active');
                if (link.getAttribute('href') === '#' + currentSection) {
                    link.classList.add('active');
                }
            });
        }
        
        window.addEventListener('scroll', updateActiveNavigation);
    </script>
</body>
</html>